More:    MJNA HOME        CANNABIS NEWS        SHOP        CONTACT 

  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
Medical Marijuana, Inc. Subsidiary HempMeds® Wins Product Registration Hearing in Puerto Rico, Begins Selling RSHO™ as First-Ever Approved Nutraceutical Product

Medical Marijuana, Inc. Subsidiary HempMeds® Wins Product Registration Hearing in Puerto Rico, Begins Selling RSHO™ as First-Ever Approved Nutraceutical Product

by adminAdrianRamirez | Jan 18, 2018 | HempMeds, Press Releases

SAN DIEGO, Jan. 18, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® had its product registrations affirmed in Puerto Rico, enabling the Company to continue...
Medical Marijuana, Inc. Announces Promotion of Chief Marketing Officer Stephen Jones to President of Subsidiary HempMeds®

Medical Marijuana, Inc. Announces Promotion of Chief Marketing Officer Stephen Jones to President of Subsidiary HempMeds®

by adminAdrianRamirez | Jan 10, 2018 | HempMeds, Press Releases

SAN DIEGO, Jan. 10, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, today announced that its Chief Marketing Officer Stephen Jones has been promoted to President of the Company’s subsidiary...
Medical Marijuana, Inc. Subsidiary HempMeds® Exhibits at The American Academy of Anti-Aging Medicine (A4M) World Conference

Medical Marijuana, Inc. Subsidiary HempMeds® Exhibits at The American Academy of Anti-Aging Medicine (A4M) World Conference

by adminAdrianRamirez | Dec 12, 2017 | HempMeds, Press Releases

SAN DIEGO, Dec. 12, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the U.S., announced today that subsidiary HempMeds® is exhibiting at The American Academy of Anti-Aging Medicine (A4M) 25th Annual World...
Medical Marijuana, Inc. Subsidiary HempMeds® Sponsors International Medical Cannabis Expo in Colombia

Medical Marijuana, Inc. Subsidiary HempMeds® Sponsors International Medical Cannabis Expo in Colombia

by adminAdrianRamirez | Nov 28, 2017 | HempMeds, Press Releases

SAN DIEGO, Nov. 28, 2017 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the U.S., announced today that subsidiary HempMeds® was a Gold Sponsor of EXPO MEDE Weed, the second International Fair of Medical Cannabis, which took...
Real Scientific Hemp Oil™ Featured in Interview with Hope4Harper Founder

Real Scientific Hemp Oil™ Featured in Interview with Hope4Harper Founder

by adminAdrianRamirez | Oct 14, 2017 | HempMeds, Media Coverage

Creator of Hope4Harper Penny Howard discusses role RSHO™ has played in her family’s day to day life. In a recent interview with the Carrollton Reader, Penny Howard reveals the story behind the organization’s annual Run4Hope, the purpose of Hope4Harper, and the...
Medical Marijuana, Inc. Subsidiary HempMeds® Exhibits at The American Academy of Anti-Aging Medicine (A4M) World Conference

Medical Marijuana, Inc. Subsidiary HempMeds® Announces Participation at Fourth Annual Cannabis World Congress and Business Exposition in Boston

by adminAdrianRamirez | Oct 4, 2017 | HempMeds, Press Releases

SAN DIEGO, Oct. 4, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, today announced that subsidiary HempMeds® will be participating in the 4th annual Boston CWCBE from October 5-6,...
« Older Entries
Next Entries »

Recent Posts

  • Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
  • Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets
  • Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Participates in Research Finding Promising Therapeutic Benefits of CBD in Parkinson’s Disease Treatment

Recent Comments

No comments to show.

Home     Company    Education     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.